-
Aug 14, 2026Molecular Imaging in NHP Models For Translational Drug DevelopmentJoin to explore how molecular imaging can move NHP research beyond anatomy and generate actionable translational evidence for drug development. -
Sep 04, 2026Why Good In Vitro Data Can Fail In Vivo: Rethinking DMPK Across Drug ModalitiesWhy do promising in vitro results fail in vivo? Explore how DMPK challenges differ across small molecules, antibodies, ADCs, peptides, and nucleic acids. -
Sep 01, 2026Imaging-Based PK/PD in Non-Human PrimatesLearn how imaging-based PK/PD in NHPs complements plasma PK by evaluating tissue distribution, target engagement, and pharmacodynamic responses.
-
Aug 28, 2026Why Animal Models Succeed Or Fail in Drug DevelopmentWhen each model is selected for a clearly defined purpose, preclinical research becomes more than a demonstration of efficacy
-
Aug 26, 2026Quantitative PET Target Engagement in NHPs For CNS DrugsLearn how quantitative PET in non-human primates measures brain exposure and target occupancy to support CNS drug development, dose selection, and translation. -
Aug 21, 2026From Video To Data: 3D AI Tracking For NHP BehaviorLearn how markerless 3D AI tracking converts NHP video into quantitative behavioral endpoints for CNS, pain, pruritus, and translational drug research. -
Aug 19, 2026PET Biodistribution Imaging in Non-Human PrimatesLearn how PET imaging enables longitudinal biodistribution studies in NHPs, with applications in vaccines, nanoparticles, biologics, and translational drug development. -
Aug 14, 2026PBPK Vs. Compartmental Models: Why PBPK MattersLearn how PBPK modeling differs from traditional PK models and supports DDI, organ impairment, pediatric dosing, food-effect, and regulatory decisions. -
Aug 07, 2026Webinar Recap: Advancing Translational NHP Research Through Digital Behaviora...Prisys Biotech recently hosted a technical webinar on AI-enabled digital behavioral phenotyping in non-human primate models. The session explored how high-resolution 3D tracking... -
Aug 05, 2026PK Biomarkers in Preclinical Drug Development | Exposure–Response & PK/PDDiscover how pharmacokinetic (PK) data can function as biomarkers in preclinical drug development, supporting target engagement, PK/PD modeling, dose selection, and translationa... -
Jul 31, 2026Spontaneous Self-Injurious Behavior in Rhesus Macaques: A Translational NHP M...spontaneous SIB macaques should be regarded as a model of specific translational endophenotypes rather than a complete reproduction of human NSSI. When combined with rigorous be... -
Jul 06, 2026NHP BehaviorAtlas Webinar | 3D NHP Behavioral Tracking For Drug DevelopmentJoin this webinar on NHP BehaviorAtlas, a high-fidelity 3D NHP behavioral tracking platform designed to transform complex NHP behaviors into quantitative, traceable, and transla...
